Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/31629445/ below:

Racial disparities in late-stage prostate cancer: a SEER analysis 2005-2015

Affiliations

• ¹ Department of Medicine and Surgery, George Washington University, Washington DC, USA.

• PMID: 31629445

Item in Clipboard

Stephanie Rodriguez et al. Can J Urol. 2019 Oct.

• ¹ Department of Medicine and Surgery, George Washington University, Washington DC, USA.

• PMID: 31629445

Item in Clipboard

Introduction: To evaluate the impact of prostate cancer screening guidelines on different racial and ethnic populations.

Materials and methods: Data was collected from the 2005-2015 Surveillance, Epidemiology, and End Results (SEER) program. Incidence of prostate cancer diagnosis was categorized and analyzed by stage, race/ethnicity, and age group. Appropriate univariate and multivariable statistical analysis was performed.

Results: The odds of being diagnosed with regional-stage prostate cancer in 2013-2015 were 1.3 times higher for black men, 1.3 times higher for Asian American/Pacific Islander (AAPI) men, and 1.2 times higher for white men when compared to 2005-2008. The odds of being diagnosed with distant-stage prostate cancer in 2013-2015 were 1.6 times higher for black men, 1.8 times higher for AAPI men, and 2.1 times higher for white men when compared to 2005-2008. In 2005-2008, 2009-2012, and 2013-2015 respectively, the odds of being diagnosed with distant-stage prostate cancer were 1.8 times higher, 1.7 times higher, and 1.4 times higher for black men compared to white men, and 1.5 times higher, 1.5 times higher, and 1.4 times higher for AAPI men compared to white men (all respective p < .001).

Conclusions: The proportion of late-stage prostate cancer has increased significantly in all US males regardless of race and/or ethnicity. From 2013-2015, all men had a higher chance of being diagnosed with regional or distant stage disease compared to years prior. Newly-diagnosed regional-stage disease increased the most over time in AAPI and black men, while distant prostate cancer increased the most over time in white men.

PubMed Disclaimer

• Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.

  Lediju O, Ikuemonisan J, Salami SS, Adejoro O. Lediju O, et al. J Racial Ethn Health Disparities. 2019 Apr;6(2):401-408. doi: 10.1007/s40615-018-00537-w. Epub 2018 Nov 30. J Racial Ethn Health Disparities. 2019. PMID: 30506310

• Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.

  Yamoah K, Lee KM, Awasthi S, Alba PR, Perez C, Anglin-Foote TR, Robison B, Gao A, DuVall SL, Katsoulakis E, Wong YN, Markt SC, Rose BS, Burri R, Wang C, Aboiralor O, Fink AK, Nickols NG, Lynch JA, Garraway IP. Yamoah K, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2144027. doi: 10.1001/jamanetworkopen.2021.44027. JAMA Netw Open. 2022. PMID: 35040965 Free PMC article.

• Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.

  Kelly SP, Rosenberg PS, Anderson WF, Andreotti G, Younes N, Cleary SD, Cook MB. Kelly SP, et al. Eur Urol. 2017 Feb;71(2):195-201. doi: 10.1016/j.eururo.2016.05.011. Epub 2016 Jul 27. Eur Urol. 2017. PMID: 27476048 Free PMC article.

• The impact of race on survival in metastatic prostate cancer: a systematic literature review.

  Freedland SJ, Samjoo IA, Rosta E, Lansing A, Worthington E, Niyazov A, Nazari J, Arondekar B. Freedland SJ, et al. Prostate Cancer Prostatic Dis. 2023 Sep;26(3):461-474. doi: 10.1038/s41391-023-00710-1. Epub 2023 Aug 17. Prostate Cancer Prostatic Dis. 2023. PMID: 37592001 Free PMC article. Review.

• Temporal trends and racial disparities in global prostate cancer prevalence.

  Rebbeck TR, Haas GP. Rebbeck TR, et al. Can J Urol. 2014 Oct;21(5):7496-506. Can J Urol. 2014. PMID: 25347377 Free PMC article. Review.

• Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?

  Gong J, Kim DM, De Hoedt AM, Bhowmick N, Figlin R, Kim HL, Sandler H, Theodorescu D, Posadas E, Freedland SJ. Gong J, et al. J Clin Oncol. 2024 Jan 10;42(2):228-236. doi: 10.1200/JCO.23.00949. Epub 2023 Oct 27. J Clin Oncol. 2024. PMID: 37890125 Free PMC article. Review.

• The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities.

  Cancino RS, Su Z, Mesa R, Tomlinson GE, Wang J. Cancino RS, et al. JMIR Cancer. 2020 Oct 29;6(2):e21697. doi: 10.2196/21697. JMIR Cancer. 2020. PMID: 33027039 Free PMC article.

• Genetic alterations in CREBRF influence prostate cancer survival and impact prostate tissue homeostasis in mice.

  Pascal LE, Frahm KA, Skalitzky KO, DeFranco DB, Rigatti LH, Lu R, Liu TT. Pascal LE, et al. Am J Clin Exp Urol. 2023 Feb 25;11(1):27-39. eCollection 2023. Am J Clin Exp Urol. 2023. PMID: 36923723 Free PMC article.

• Racial, ethnic, and socioeconomic disparities in rates of stage IV prostate cancer after USPSTF category "D" recommendation against prostate-specific antigen screening: a retrospective cohort study.

  Thakker PU, Perry AG, Hemal AK, Bercu CH, Petrou SP, Pak RW, Broderick GA, Thiel DD, Dora CD, Lyon TD, Igel TC, Craven TE, Pathak RA. Thakker PU, et al. Transl Androl Urol. 2024 Jul 31;13(7):1093-1103. doi: 10.21037/tau-24-90. Epub 2024 Jul 16. Transl Androl Urol. 2024. PMID: 39100847 Free PMC article.

• Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.

  Lai SM, Keighley J, Garimella S, Enko M, Parker WP. Lai SM, et al. JAMA Netw Open. 2022 Nov 1;5(11):e2240657. doi: 10.1001/jamanetworkopen.2022.40657. JAMA Netw Open. 2022. PMID: 36342715 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3